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Ron-Bin Hsu, MD, and Fang-Yue Lin, MD, Taipei, Taiwan, Republic of China
Background: Infected aneurysm of the thoracic aorta is rare and can be fatal without surgical treatment. We review our
experience with 32 patients during a 12-year period.
Methods: Retrospective chart review.
Results: Between 1995 and 2007, 32 patients (24 men, 8 women) with infected aneurysms of thoracic aorta were treated
at our hospital. Their median age was 74 years (range, 50-88 years). Of the 28 pathogens isolated, the most common
responsible microorganism was nontyphoid Salmonella in 16 (57%), followed by Staphylococcus aureus in four (14%) and
Mycobacterium tuberculosis in three (11%). The site of infection was the aortic arch in 13 patients, proximal descending
thoracic aorta in 10, and distal descending thoracic aorta in 9. Seven patients had medical treatment alone, and 25 patients
underwent in situ graft replacement. The hospital mortality rate of medical treatment alone was 57%, and the hospital
mortality rate of in situ grafting was 12%. Of the 22 operated-on survivors, there were 11 late deaths, four of which were
aneurysm-related. The aneurysm-related mortality rate in operated-on patients was 28%. Of 16 patients with infection
caused by nontyphoid Salmonella, 13 patients underwent in situ grafting, with a hospital mortality rate of 8% and
aneurysm-related mortality rate of 31%.
Conclusions: Infected aneurysm of the thoracic aorta was uncommon. The clinical results of in situ grafting were
improving. Nontyphoid Salmonella was the most common responsible microorganism, and the prognosis of infection
caused by Salmonella was not dismal. Outcomes of other management strategies, such as endovascular stenting, need to
be compared with these results. ( J Vasc Surg 2008;47:270-6.)An infected aneurysm of the aorta and adjacent arteries
is a rare but life-threatening condition.1-10 The mortality
rate is extremely high without surgical treatment, with
reported rates of 16% to 44%.1-10 Hospital survival was
reported to be poor in those patients with severe aortic
infection, infection caused by Salmonella spp or Staphylo-
coccus aureus, presence of aneurysm rupture, and especially,
depending on the location of the infected thoracic aortic
aneurysm.
Infected aneurysm of the thoracic aorta is even rarer,
and only sporadic case reports of infected aneurysms of the
thoracic aorta have been published.11-13 The reported an-
eurysm-related mortality rate was high, from 30% to 50%.
The clinical outcome was especially poor in patients with
infection caused by nontyphoid Salmonella.11
Infected aortic aneurysm is common in Taiwan and
Hong Kong.14-19 We have reported that with timely surgi-
cal intervention and prolonged intravenous antibiotic ther-
apy, surgery with in situ graft replacement provides a good
outcome in patients with an infected aortic aneurysm.16,17
However, only 13 cases of infected thoracic aortic aneu-
rysm were reported then. Here, we review our experience
with 32 patients who had an infected thoracic aortic aneu-
rysm during a 12-year period.
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270METHODS
Setting. National Taiwan University Hospital (Taipei,
Taiwan) is a 2200-bed tertiary care hospital. It serves an
urban population of 2 million persons as both first-line and
tertiary facilities. It serves also as a referral center for other
hospitals in the country with a population of 22 million
persons.
Patients. The study patient cohort was obtained from
a retrospective analysis of the clinical data for patients with
infected aneurysms of the thoracic aorta from September
1995 to June 2007. Patients with infection of ascending
aorta, thoracoabdominal aorta, and abdominal aorta were
excluded.
Diagnosis. The diagnosis of infected aneurysm was
made by a combination of clinical evidence of infection,
imaging evidence of infected aorta, and pathologic evi-
dence of inflammation. We excluded patients with thora-
coabdominal, iatrogenic, or traumatic aneurysms. Clini-
cally, infected aortic aneurysm was usually preceded by an
infected aorta or aortitis. An infected aorta was diagnosed
with clinical evidence of infection (fever and leukocytosis)
and periaortic soft tissue infiltration demonstrated by a
computed tomography or magnetic resonance imaging
study.20 Blood and tissue culture was repeated to find the
responsible microorganism. The diagnosis of infected an-
eurysm was further confirmed by the presence of frank pus
during the operation and the presence of acute suppurative
inflammation or bacterial clumps, or both, on pathologic
examination.21
Medical treatment. As described previously,16,17 an
intravenous antibiotic was given once the diagnosed was
confirmed. Patients with Salmonella spp infections received
intravenous ceftriaxone (1000-2000 g every 12 hours). For
patients with non-Salmonella infections, the antibiotic use
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patients with good response to antibiotic treatment (no
fever, no localized pain and declining white cell count),
surgical intervention was considered after the infection was
controlled. The imaging study was repeated if patients had
a new symptom or sign suggesting aortic pseudoaneurysm
formation (shock, a new localized pain, or a new palpable
mass) or after complete antibiotic treatment.
Early surgical intervention, which was defined as an
operation before the infection was controlled, was per-
formed only in the situations of uncontrolled infection
(persistent fever or septic shock) or if there was evidence of
impending aortic rupture demonstrated by persistent pain,
shock, or enlarging pseudoaneurysm formation on the
repeated imaging study.
Surgical treatment. Surgical management consisted
of wide débridement of infected tissue, copious saline irri-
gation, and in situ repair with a Dacron graft (DuPont,
Wilmington, Del). Neither homografts nor antibiotic
bonded grafts were available.
The selected operative approach depended on the sur-
geon’s preference. Median sternotomy was selected in pa-
tients with proximal aortic arch or distal aortic arch aneu-
rysms. Cardiopulmonary bypass was instituted through
arterial cannulation of ascending aorta or right subclavian
artery and venous cannulation of right atrium.
The reconstruction of the aortic arch and arch vessels
was performed under deep hypothermic circulatory arrest.
Methods of brain protection during circulatory arrest, in-
cluding deep hypothermia alone, retrograde cerebral per-
fusion, and selective antegrade cerebral perfusion, also de-
pended on the surgeon’s preference.
Left posterolateral thoracotomy was selected for pa-
tients with distal arch or descending thoracic aneurysms.
Cardiopulmonary bypass was instituted through arterial
cannulation of femoral artery and venous cannulation of
femoral vein.
For those patients with distal arch aneurysms, a proxi-
mal aortic anastomosis was performed under deep hypo-
thermic circulatory arrest and no adjunctive cerebral perfu-
sion. For those patients with descending thoracic
aneurysms, a proximal and distal aortic anastomosis was
performed under aortic clamping.
Antibiotics were administered intravenously in the hos-
pital for at least 6 to 8 weeks and until the clinical and
laboratory variables of fever, white cell count, and C-
reactive protein were normalized. The antibiotic was con-
tinued orally after discharge, with the duration of at least 6
months or according to the surgeon’s preference.
Data collection. Data on age, sex, medical comorbidi-
ties, operation status, location of infected aneurysms, sur-
gical procedure, and clinical outcome were collected retro-
spectively from medical records. For those patients not
followed up at our outpatient clinic, follow-up information
and survival data were obtained by telephone contact or
from the National Death Index. Aneurysm-related mortal-
ity was defined as a death caused by persistent infection or
postoperative complications directly related to the opera-tion. A death that occurred1year after operation and was
caused by a diagnosis not related to the infected aneurysm
was considered not aneurysm-related. Patients who sur-
vived 1 year were considered disease-free.
RESULTS
Patient characteristics. From 1995 to 2007, 32 pa-
tients (24 men and 8 women) with infected aneurysms of
the thoracic aorta were treated in our hospital. The patient
demographics are summarized in Tables I, II, and III.
Their median age was 74 years (range, 50-88 years). The
medical comorbidities included hypertension in 9 patients,
diabetes mellitus in 11, chronic obstructive pulmonary
disease in 3, coronary artery disease in 7, pulmonary tuber-
culosis in 5, end-stage renal disease with regular hemodial-
ysis in 3, and liver cirrhosis in 2.
At presentation, 24 patients were febrile and 16 pa-
tients had localized chest or back pain. One patient was in
shock status at the time of presentation. Four patients
presented with consciousness disturbance, five with he-
moptysis, and two with hemothorax. The four patients
presenting with disturbance of consciousness had an in-
fected aortic arch aneurysm, and one patient had acute left
middle cerebral artery ischemic stroke because of external
compression of left common carotid artery by an infected
distal arch pseudoaneurysm (Table I).
The initial imaging findings were aortitis in one patient
and aortic pseudoaneurysm or saccular aneurysm in 31
patients. The pseudoaneurysms were 2.3 to 10 cm in
maximal diameter. The site of infection was the aortic arch
in 13 patients, proximal descending thoracic aorta in 10,
and the distal descending thoracic aorta in nine.
Microbiology. All patients except four had a blood or
tissue culture result positive for a microorganism. Of the 28
isolates, the most common responsible microorganism was
nontyphoid Salmonella in 16 patients (57%), followed by
Staphylococcus aureus in 4 (14%),Mycobacterium tuberculo-
sis in 3 (11%), Escherichia coli in 2 (7%), Streptococcus
pneumoniae in 2 (7%), andKlebsiella pneumoniae in 1. The
serotypes of isolated nontyphoid Salmonella spp were S
choleraesuis in 5, S enteritidis in 6, and S typhimurium in 5.
Treatment. Operation was refused in seven patients,
because of old age in four, severe medical comorbidities in
two, and one patient was at high surgical risk. In situ graft
replacement was done in 25 patients, none of which under-
went extra-anatomic bypass. The median duration of pre-
operative antibiotic use was 8 days (range, 0-45 days). The
aneurysm location, treatment, and outcome are summa-
rized in the Fig.
Aortic arch. Three of the 13 patients with infected
aortic arch aneurysm received medical treatment only, and
10 patients underwent in situ graft replacement (Fig). One
of the three patients with medical treatment alone died of
aneurysm rupture 1 day after admission.
The operation was performed through median sternot-
omy in four patients and thoracotomy in six. One of the 10
patients undergoing in situ graft replacement died, for a
hospital mortality rate of 10%. The only hospital death
; TB,
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infected aneurysm caused by methicillin-resistant S aureus.
He underwent urgent operation because of progressive left
cerebral hemispheric ischemic stroke caused by localized
rupture of infected aneurysm and compression of left com-
mon carotid artery. He died of early prosthetic graft infec-
tion and overwhelming sepsis 4 weeks after the operation.
Seven of 10 patients (70%) had major postoperative
complications (Table I). Postoperative hypoxic encepha-
lopathy with persistent neurologic deficits occurred in four
patients, respiratory failure with prolonged ventilator sup-
port occurred in two, and reoperation for bleeding, sternal
wound infection, nosocomial bacteremia, surgical wound
infection, and early prosthetic graft infection each occurred
in one patient. Three of the four patients with preoperative
consciousness disturbance recovered, and one patient had
postoperative hypoxic encephalopathy. Five late deaths oc-
curred because of multiple organ failure in three patients,
late prosthetic graft infection in one patient, and heart
disease in one patient (Table I). In summary, the aneurysm-
Table I. Data of 13 patients with infected aneurysms of th
No. Sex Age, y Pathogen Clinical pr
1 M 67 S typhimurium Fever
2 M 57 S choleraesuis Fever, chest
3 M 58 K pneumoniae Fever, LoC
4 M 79 S enteritidis Fever
5 F 66 S choleraesuis Fever
6 M 79 E coli Fever, LoC,
7 M 78 Ss aureus Fever, ischem
8 M 68 S aureus Fever
9 M 50 S enteritidis Fever, hoarse
10 F 70 S pneumoniae Hemoptysis,
11 M 70 S choleraesuis Fever
12 M 49 S choleraesuis Fever
13 M 82 Unknown Fever
PSA, Pseudoaneurysm;DM, diabetes mellitus; CAD, coronary artery disease
obstructive pulmonary disease.
Table II. Data of 10 patients with infected aneurysms of t
No. Sex Age, y Pathogen Clinical presentati
1 M 82 M tuberculosis Fever, chest pain hemo
2 F 69 S typhimurium Fever, urinary tract inf
3 F 61 Unknown Respiratory failure
4 F 84 M tuberculosis Back pain, hemoptysis
5 F 77 S enteritidis Fever, chest pain
6 M 68 S aureus Chest pain, hemoptysi
7 M 88 S typhimurium Fever, chest pain
8 M 80 M tuberculosis Hemoptysis
9 M 83 S aureus Fever
10 M 75 Unknown Chest pain
TB, Tuberculosis; PSA, pseudoaneurysm; BDM, diabetes mellitus; HT, hyp
disease; MRSA, methicillin-resistant Staphylococcus aureus.related mortality rate of in-situ grafting in patients with
infected aortic arch aneurysm was 40%, and the disease-free
survival at 1 year was 50% (Fig).
Proximal descending thoracic aorta. Four of the 10
patients with an infected proximal descending thoracic
aortic aneurysm received medical treatment alone, and
six underwent in situ graft replacement through postero-
lateral thoracotomy (Fig). Of the four patients with
medical treatment alone, three died of aneurysm rupture
at 5, 11, and 16 days after admission, and one patient
died suddenly at home about 3 months after treatment.
There was no hospital mortality in 6 patients undergoing
in situ graft replacement. Major postoperative complica-
tions occurred in two of six patients (33%) and included
respiratory failure with prolonged ventilator support and
bacteremia caused by methicillin-resistant S aureus. In
summary, the aneurysm-related mortality rate of in situ
grafting in patients with proximal descending thoracic
aortic aneurysm was 0% and the disease-free survival at 1
year was 83% (Fig).
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patients with infected distal descending thoracic aortic an-
eurysm received medical treatment alone, and nine patients
underwent in situ graft replacement through thoracotomy
(Figure). The hospital mortality rate in the nine patients
who had in situ graft replacement was 22% (2 of 9). The
causes of hospital death were early prosthetic graft infection
and esophageal perforation (Table III). Major postopera-
tive complications occurred in five of nine (56%) patients.
Early prosthetic graft infection occurred in two patients,
and respiratory failure with prolonged ventilator support,
reoperation for bleeding, wound infection, nosocomial
bacteremia, and esophageal perforation each occurred in
one patient. Of the two patients with early graft infection,
one patient received conservative treatment but died, and
one recovered after flap reconstruction (Table III). One
patient died 11 months after operation because of renal
failure. In summary, the aneurysm-related mortality rate of
in situ grafting in patients with distal descending thoracic
aortic aneurysm was 33% and the disease-free survival at 1
year was 67% (Fig).
Table I. Continued.
Operation, extent of arch
replacement Hospital outcome
In situ grafting; partial distal arch Alive Respir
ence
In situ grafting; partial distal arch Alive Woun
In situ grafting; partial distal arch Alive None
In situ grafting; total arch Alive Hypox
In situ grafting; partial distal arch Alive Respir
bact
In situ grafting; partial distal arch Alive Hypox
In situ grafting; total arch Died early prosthetic
infection
Early p
In situ grafting; total arch Alive Hypox
blee
In situ grafting; partial distal arch Alive None
In situ grafting; partial distal arch Alive None
None Alive
None Alive
None Died
Table II. Continued.
Operation Hospital outcome
In situ grafting Alive
In situ grafting Alive
In situ grafting Alive
In situ grafting Alive
In situ grafting Alive
In situ grafting Alive
None Died aneurysm rupture
None Alive
None Died aneurysm rupture
None Died aneurysm ruptureOverall, the hospital mortality rate of medical treat-
ment alone was 57% and the hospital mortality rate of
in-situ graft replacement was 12% (Fig).
Late outcome. Themedian follow-up duration for the
22 operated-on survivors was 16 months (range, 2-134
months). Follow-up information was complete in all pa-
tients. There were 11 late deaths, of which four were
aneurysm-related, and seven were not.
One of the aneurysm-related mortalities occurred in
57-year-old man with late prosthetic graft infection in an
aortic arch aneurysm caused by S choleraesuis. He under-
went a successful operation after the preoperative use of
ceftriaxone for 8 days. However, he died of aortoenteric
fistula and massive bleeding 4 months after the operation
(Table I). One 79-year-old man with an infected aortic arch
aneurysm caused by S enteritidis underwent an emergency
operation that was complicated with hypoxic encephalop-
athy. He was discharged with long-term tracheostomy care
but died of multiple organ failure 3 months after the
operation (Table I). A 68-year-old man with an infected
aortic arch aneurysm caused by S aureus underwent an
t-op complication Late outcome
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encephalopathy. He was discharged with long-term trache-
ostomy care but died of multiple organ failure 9 months
after operation (Table I). One 81-year-old woman with an
infected distal thoracic aortic aneurysm caused by S enteri-
tidis underwent an emergency operation that was compli-
cated with respiratory failure. She was discharged with
long-term tracheostomy care but died of renal failure 11
months after operation (Table III).
Of the seven deaths that were not aneurysm-related,
acute respiratory failure occurred in a 61-year-old woman
with an infected proximal descending thoracic aortic aneu-
rysm who had a medical history of chronic obstructive
pulmonary disease. She underwent a successful operation,
but died of acute respiratory failure 3 months after the
operation. The repeat imaging study showed no evidence
of recurrent graft infection (Table II). Six patients died 1
year after operation because of heart disease in 1 (Table I),
multiple organ failure in 1 (Table I), prostate carcinoma in
1 (Table III), sepsis in 1 (Table III), and an unknown cause
in 2 (Table II).
In summary, the aneurysm-related mortality rate of in
situ graft replacement in patients with infected thoracic
aortic aneurysm was 28% (7 of 25; Fig). Of the 23 patients
undergoing in situ graft replacement before July 2006, 15
patients (65%) were alive and infection-free at 1 year after
operation.
DISCUSSION
Infected thoracic aortic aneurysm. Infected aneu-
rysms of the thoracic aorta are extremely rare.11-13 S aureus
and Salmonella spp are the predominant pathogens. Pre-
senting symptoms are often nonspecific. Because of insidi-
ous onset, the clinical presentation is often due to the
complication of aneurysm rupture.13
Surgery remains the definitive treatment, but in the
early years, the hospital mortality rate and the aneurysm-
relatedmortality rate was as high as 38% and 40% in patients
with infected suprarenal or thoracic aortic aneurysm.1,8
However, the reported clinical experience is limited to
small series and case reports.1-12
The largest single-center experience of 11 patients with
infected thoracic aortic aneurysm was reported in 2003.
Table III. Data of nine patients with infected aneurysms o
No. Sex Age, y Pathogen Clinical pre
1 M 74 S typhimurium Fever
2 F 74 E coli Fever, chest
3 M 51 S enteritidis Fever, chest
4 M 78 Unknown Fever, dyspn
5 F 81 S enteritidis Fever, back
6 M 84 S typhimurium Shock,
7 M 74 S enteritidis Fever, back
8 M 56 S choleraesuis Chest pain
9 M 56 S pneumoniae Fever, back
TB, Tuberculosis; PSA, pseudoaneurysm; DM, diabetes mellitus; HT, hypeThere were four ascending aortic aneurysms, four aorticarch aneurysms, and three descending thoracic aortic aneu-
rysms. Nine patients underwent surgery, and one died, for
a hospital mortality rate of 11%. None of the eight operative
survivors had evidence of recurrent infection with a fol-
low-up duration of 19 months.13
In this current series, 32 patients had an infected tho-
racic aortic aneurysm. None of our patients had ascending
aortic infection, 13 had an aortic arch aneurysm, and 19
had a descending thoracic aortic aneurysm. The initial
imaging study showed that 96% of our patients had
aneurysm rupture or pseudoaneurysm formation.
Of the 25 operated on cases, the hospital mortality rate
of 12% and aneurysm-related mortality rate of 28% were
much lower than the rates in previous reports.1,8,11-13 The
clinical results of current treatment method using in situ
graft replacement are improving. The low mortality rate
was probably attributed to clinical alertness and the exten-
sive surgical experience of treating infected aortic aneu-
rysms in Taiwan.16,17 Nevertheless, major postoperative
complications, including prosthetic graft infection and hy-
poxic encephalopathy in infected aortic arch aneurysms,
were still problems. In this current series, the incidence of
prosthetic graft infection was 16% (3 early and 1 late).
The possible ways to improve the outcomes include
aggressive surgical débridement, possibly placement of
pedicled vascular tissue such as omentum or intercostals
muscle to separate the graft from an infected bed of tissue,
and the use of antibiotic-bonded grafts, autogenous grafts,
or cryopreserved allografts. Previous studies have shown
that the use of pedicled flap, antibiotic-bonded graft, au-
togenous grafts, and cryopreserved allograft is an effective
strategy for treating aortic infection.22-25 However, the
clinical experience is limited in only small case series. Cer-
tain antibiotic-bonded grafts, such as rifampin-soaked gel-
atin-sealed polyester grafts, are not effective against infec-
tion caused by Salmonella spp or methicillin-resistant S
aureus.26 Further studies are needed to prove these points.
In addition, although preoperative consciousness dis-
turbance was present in four of 10 patients with an infected
aortic arch aneurysm, postoperative hypoxic encephalopa-
thy occurred in four of nine operated-on survivors (Table
I). Proper use of adjunctive cerebral perfusion during deep
hypothermic circulatory arrest probably will improve the
e distal descending thoracic aorta
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rysms carries significant mortality and morbidity. Endovas-
cular stent grafts combined with antibiotic therapy may be
an alternative to conventional thoracotomy in managing
infected aneurysms of the thoracic aorta. The preliminary
results are encouraging27,28 However, the use of endovas-
cular stent grafts in the treatment of infected thoracic
aneurysm is contentious because the lack of surgical
débridement confers the risk of continued infection and the
long-term durability of stent grafts is still unclear.29
Salmonella infection. In Western countries, the most
common responsible organism of infected aortic aneurysm
was S aureus and Streptococcus spp.1-10 In Taiwan, nonty-
phoid Salmonella was the most common pathogen.14-19
Fig. Aneurysm location, treatment, and outcome i
Table III. Continued.
Operation
Hospital
outcome Postoperat
In situ grafting Alive None
In situ grafting Alive Seizure
In situ grafting Alive None
In situ grafting Died sepsis Re-op for bleeding, early g
In situ grafting Alive Respiratory failure, wound
In situ grafting Died sepsis Esophageal perforation
In situ grafting Alive Early graft infection
In situ grafting Alive None
In situ grafting Alive NoneSalmonella-infected aneurysms of the thoracic aorta are rareand the prognosis is poor.30,31 In a collected series of 14
previously reported patients with Salmonella-infected an-
eurysms of the thoracic aorta, the overall outcome was
abysmal, with 10 patients undergoing operation and six
patients (60%) dying 1 month after the diagnosis.11 In
this current series, however, 16 patients had infected tho-
racic aortic aneurysms caused by nontyphoid Salmonella
(Tables I-III). Three patients had medical treatment alone,
and one patient died of aneurysm rupture (33%). Thirteen
patients underwent in situ graft replacement, with a hospi-
tal mortality rate of 8% and an aneurysm-related mortality
rate of 31%. The prognosis of infected thoracic aortic
aneurysm caused by nontyphoid Salmonella was not dis-
ents with infected aneurysms of the thoracic aorta.
mplication Late outcome
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Alive 134 mon
Alive 112 mon
fection
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are that it was retrospective and lacked long-term follow-up
information. Because it was retrospective, there was no
consistent approach to these patients and the duration of
preoperative antibiotic use was also variable. However, to
our knowledge, this study is the largest case series ever
reported in the literature and provides useful information of
treating infected aneurysms of the thoracic aorta.
CONCLUSION
Infected aneurysm of the thoracic aorta was uncom-
mon. The clinical results of in situ grafting were improving.
Nontyphoid Salmonella was the most common responsible
microorganism, and the prognosis of infection caused by
Salmonella was not dismal. Outcomes of other manage-
ment strategies, such as endovascular stenting, for infected
thoracic aortic aneurysm need to be compared with these
results.
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